Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
oleh: Eric R. Gregory, Lucy Stun, Matt J. Mason, Nicole M. Wilson, Kassem A. Hammoud
| Format: | Article |
|---|---|
| Diterbitkan: | Cambridge University Press 2022-01-01 |
Deskripsi
The updated vancomycin guideline for treatment of serious methicillin-resistant Staphylococcus aureus infections prompted institutions to convert from trough to area-under-the-curve monitoring. The physician perception of the transition, coupled with that of pharmacists, was measured by pre- and postimplementation surveys. Both groups believed safety would be increased without efficacy changes.